BraveBites are delicious cookies specially developed for dogs with cancer. They are not only full of flavour and enhance appetite, but the treats also contain specific ingredients to support dogs with cancer during their difficult period.
The BraveBites snacks have been carefully developed by veterinarians to lovingly pamper and care for your favourite four-legged friend. BraveBites was developed by Camille De Ley, a veterinarian with a special interest in oncology.
Unfortunately, 1 in 4 dogs develops cancer, and in dogs older than 10 years, it's even half. Since these beautiful pets are often considered part of the family, the field of oncology within veterinary medicine has grown significantly. A vital component of treatment is nutrition. The unique composition of BraveBites promotes the quality of life, well-being, and therefore, the comfort of your dog with cancer.
"With BraveBites, we've created a snack that is not only tasty and nutritious but also promotes the well-being of the dog in challenging times. I hope to support not only the loyal four-legged friends but also the owners." – Camille
Company Details
- Employees
- 1
- Founded
- -
- Address
- Canadastraat 7, Moerkerke,flemish Region 8340,belgium
- Industry
- Animal Feed Manufacturing
- NAICS
-
Animal Food ManufacturingDog and Cat Food ManufacturingOther Animal Food Manufacturing
- Website
- http://www.bravebitespetfood.com
- HQ
- Moerkerke, Flemish Region
Bravebites Questions
Bravebites's website is http://www.bravebitespetfood.com
Bravebites's LinkedIn profile is https://be.linkedin.com/company/bravebites
Bravebites has
1 employees.
View email and phone details for 1
employees at Bravebites.
Bravebites's industry is
Animal Feed Manufacturing
Bravebites's top competitors are
Toolmaster,
Chayah,
Babyloop,
Buß Byproducts Gmbh,
Miavit Food Gmbh,
The Petfood Company Gmbh,
Lico Heimtiernahrung Gmbh,
Strayz Petfood Gmbh,
Fediaf - The European Pet Food Industry,
Anicura Nederland.
Bravebites's categories are Animal Feed Manufacturing
Bravebites's founding year is 2023
